Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

January

03
2016

Sensus Healthcare Reports Third Quarter 2016 Results

– Q3 revenues increased 58% year-over-year to $3.33 million –…

January

03
2016

Sensus Healthcare Reports Third Quarter 2016 Results

– Q3 revenues increased 58% year-over-year to $3.33 million –…

January

31
2016

Patients Benefit from Non-Surgical SRT

If you’ve been diagnosed with non-melanoma skin cancer, such as…

January

26
2016

Physicians Prefer SRT Therapy for Treatment of Non-Melanoma Skin Cancer and Keloid Scars

Eighteen million people are affected by unsightly and sometimes painful…